Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Cash & Equivalents (2021 - 2025)

Tenon Medical has reported Cash & Equivalents over the past 5 years, most recently at $3.8 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $3.8 million for Q4 2025, down 42.52% from a year ago — trailing twelve months through Dec 2025 was $3.8 million (down 42.52% YoY), and the annual figure for FY2025 was $3.8 million, down 42.52%.
  • Cash & Equivalents for Q4 2025 was $3.8 million at Tenon Medical, up from $3.4 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for TNON hit a ceiling of $10.3 million in Q1 2025 and a floor of $2.0 million in Q2 2024.
  • Median Cash & Equivalents over the past 5 years was $3.8 million (2025), compared with a mean of $4.9 million.
  • Biggest five-year swings in Cash & Equivalents: plummeted 66.37% in 2024 and later surged 298.68% in 2025.
  • Tenon Medical's Cash & Equivalents stood at $2.9 million in 2021, then dropped by 27.01% to $2.1 million in 2022, then grew by 14.04% to $2.4 million in 2023, then surged by 169.15% to $6.5 million in 2024, then crashed by 42.52% to $3.8 million in 2025.
  • The last three reported values for Cash & Equivalents were $3.8 million (Q4 2025), $3.4 million (Q3 2025), and $7.8 million (Q2 2025) per Business Quant data.